Abstract

Abstract

Ranitidine is a well-tolerated H2-receptor antagonist commonly used in peptic ulcer treatment and stress ulcer prophylaxis. Anaphylaxis is rarely observed with ranitidine. We report the case of a patient who developed anaphylaxis after intravenous injection of ranitidine for acute COPD exacerbation. This article underlines the importance of awareness that in COPD acute exacerbation treatment, ranitidine, which is usually administered with methylprednisolone, also has anaphylaxis potential.

Cite this article as:

Yılmaz İ, Türk M. Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation. Turk Thorac J 2017;18:94-5.